Current HSG Clinical Trials & Studies

HSG has current, active opportunities to participate in a clinical trial. Some studies may be therapeutic trials (experimental or known compounds/drugs are used), while others may be observational studies (no drugs are used). Read the Clinical Trial FAQ to learn more.

If you are interested in taking part in a study, the HSG can help you determine what trial might be right for you. Please contact an HSG Research Site or the the Huntington Study Group directly by phone 800-487-7671 (toll free from the U.S. and Canada) or email (info@hsglimited.org) for more information.

If you would prefer to have the HSG reach you directly about new research opportunities, please sign up to be contacted about future clinical trials and observational studies here.

Currently Enrolling

A Phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of pridopidine in patients with early stage of Huntington disease.

 Learn more about PROOF-HD

 Contact me about this trial or future research

  Currently Enrolling

An Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated with Huntington Disease.

 Learn more about KINECT-HD2

 Contact me about this trial or future research

  Enrollment Closed

A Phase 3, randomized, double-blind, placebo-controlled study to Evaluate the efficacy of valbenazine to reduce chorea associated with HD, evaluate the safety and tolerability of valbenazine in subjects with HD, and evaluate the ability of wearable movement sensors to detect changes in physical activity (optional activity).

 Learn more about KINECT-HD

 Contact me about this trial or future research


Video: Benefits to Participation in a Clinical Trial

For more information visit clinicaltrials.gov and hdtrialfinder.org